BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 26372817)

  • 1. Validation of the Besta Neurological Institute rating scale for myasthenia gravis.
    Antozzi C; Brenna G; Baggi F; Camera G; Maggi L; Rezzani C; Montomoli C; Mantegazza R
    Muscle Nerve; 2016 Jan; 53(1):32-7. PubMed ID: 26372817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validity, reliability, and sensitivity to change of the myasthenia gravis activities of daily living profile in a sample of Italian myasthenic patients.
    Raggi A; Antozzi C; Baggi F; Leonardi M; Maggi L; Mantegazza R
    Neurol Sci; 2017 Nov; 38(11):1927-1931. PubMed ID: 28780706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A reliability study of impairment and disability scales for myasthenia gravis patients.
    Romani A; Piccolo G; Bergamaschi R; Versino M; Cosi V
    Funct Neurol; 2002; 17(3):137-44. PubMed ID: 12549719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of the italian version of the 15-item Myasthenia Gravis Quality-of-Life questionnaire.
    Raggi A; Leonardi M; Ayadi R; Antozzi C; Maggi L; Baggi F; Mantegazza R
    Muscle Nerve; 2017 Oct; 56(4):716-720. PubMed ID: 28029697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The MG composite: an outcome measure for myasthenia gravis for use in clinical trials and everyday practice.
    Burns TM
    Ann N Y Acad Sci; 2012 Dec; 1274():99-106. PubMed ID: 23252903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of the Italian version of the Myasthenia Gravis Impairment Index (MGII).
    Pasqualin F; Barnett C; Guidoni SV; Albertini E; Ermani M; Bonifati DM
    Neurol Sci; 2022 Mar; 43(3):2059-2064. PubMed ID: 34505205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The MG Composite: A valid and reliable outcome measure for myasthenia gravis.
    Burns TM; Conaway M; Sanders DB;
    Neurology; 2010 May; 74(18):1434-40. PubMed ID: 20439845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The modified rankin scale to assess disability in myasthenia gravis: Comparing with other tools.
    Farrugia ME; Carmichael C; Cupka BJ; Warder J; Brennan KM; Burns TM
    Muscle Nerve; 2014 Oct; 50(4):501-7. PubMed ID: 24639179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and validation of the Myasthenia Gravis TeleScore (MGTS).
    Pasqualin F; Guidoni SV; Albertini E; Ermani M; Frangiamore R; Vanoli F; Antozzi C; Mantegazza R; Bonifati DM
    Neurol Sci; 2022 Jul; 43(7):4503-4509. PubMed ID: 35226211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of the MG-DIS: a disability assessment for myasthenia gravis.
    Raggi A; Leonardi M; Schiavolin S; Antozzi C; Brenna G; Maggi L; Mantegazza R
    J Neurol; 2016 May; 263(5):871-882. PubMed ID: 26931109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physician- and self-assessed myasthenia gravis activities of daily living score.
    Lee HL; Min JH; Seok JM; Cho EB; Cho HJ; Kim YD; Kim BJ
    Muscle Nerve; 2018 Mar; 57(3):419-422. PubMed ID: 28796382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myasthenia gravis: a quantitative evaluation system. Disability status scale (DSS) applied for myasthenia gravis.
    Szobor A
    Eur Neurol; 1976; 14(6):439-46. PubMed ID: 991881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The quantitative myasthenia gravis score: comparison with clinical, electrophysiological, and laboratory markers.
    Barnett C; Katzberg H; Nabavi M; Bril V
    J Clin Neuromuscul Dis; 2012 Jun; 13(4):201-5. PubMed ID: 22622164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Translation and validation of the arabic version of the revised 15-item myasthenia gravis quality-of-life questionnaire.
    Alanazy MH; Abuzinadah AR; Muayqil T
    Muscle Nerve; 2018 Apr; 57(4):581-585. PubMed ID: 28857210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preliminary Findings of a Dedicated Ocular Myasthenia Gravis Rating Scale: The OMGRate.
    Wong SH; Eggenberger E; Cornblath W; Xhepa A; Miranda E; Lee H; Burke A; Barnett C
    Neuroophthalmology; 2020 Jun; 44(3):148-156. PubMed ID: 32395166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychometric evaluation of the myasthenia gravis composite using Rasch analysis.
    Sadjadi R; Conaway M; Cutter G; Sanders DB; Burns TM;
    Muscle Nerve; 2012 Jun; 45(6):820-5. PubMed ID: 22581534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and validation of the Myasthenia Gravis Impairment Index.
    Barnett C; Bril V; Kapral M; Kulkarni A; Davis AM
    Neurology; 2016 Aug; 87(9):879-86. PubMed ID: 27402891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Oculobulbar Facial Respiratory score is a tool to assess bulbar function in myasthenia gravis patients.
    Farrugia ME; Harle HD; Carmichael C; Burns TM
    Muscle Nerve; 2011 Mar; 43(3):329-34. PubMed ID: 21305562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The utility of a single simple question in the evaluation of patients with myasthenia gravis.
    Abraham A; Breiner A; Barnett C; Katzberg HD; Bril V
    Muscle Nerve; 2018 Feb; 57(2):240-244. PubMed ID: 28590545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new scale for the assessment of performance and capacity of hand function in children with hemiplegic cerebral palsy: reliability and validity studies.
    Rosa-Rizzotto M; VisonĂ  Dalla Pozza L; Corlatti A; Luparia A; Marchi A; Molteni F; Facchin P; Pagliano E; Fedrizzi E;
    Eur J Phys Rehabil Med; 2014 Oct; 50(5):543-56. PubMed ID: 24732444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.